Max Healthcare, Imperial College launch diabetes study
Advertisement
New Delhi: Max Healthcare has partnered with Imperial College, London, and the European Commission to launch a 3-year 'iHealth Type2 Diabetes' study in which 10,000 people from India will be screened.
"The study will map 10,000 citizens of India with pre- diabetic symptoms and will focus on health promotion and prevention of Type2 Diabetes (T2D) among South Asians," Max Healthcare said in a statement.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.